Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Inspection References

Inspection References

                        FDA's Remote Oversight Tools
          Inspection Citation
          Inspection Observations
          ORA Outbreak Response Field Guides


                        Inspection Guides
          Investigations Operations Manual
          Field Management Directives
          Foreign Inspections
          Nonclinical Laboratories Inspected under Good Laboratory Practices Home
          Inspections, Compliance, Enforcement, and Criminal Investigations
          Inspection References
          FDA's Remote Oversight ToolsInspection References FDA's Remote Oversight Tools
  
  	
    Share
    Post
    Linkedin

    Email
    PrintThe FDA uses of a variety of surveillance tools and developed new oversight approaches to enable the agency to provide oversight to as many facilities as possible, while utilizing our resources to protect and promote public health.

Remote regulatory assessments (RRAs) include voluntary interactive evaluations (such as remote livestreaming video of operations, teleconferences and screen sharing) in addition to requests to review records and other information under existing statutory or regulatory authority. Throughout the pandemic, the FDA has used these tools, domestically and abroad, to help the agency conduct oversight, mitigate risk, and meet critical public health needs.

Remote Regulatory Assessments (RRA) Types of Assessment
The agency uses RRAs when we determine that an RRA is an appropriate step in assessing compliance with FDA regulations. Through RRAs, we can (among other things):

assess compliance of FDA-regulated products and manufacturing processes, which may enable a firm to make corrective actions prior to their next inspection;
	assess the adequacy of corrective actions taken in response to previous inspections of compliant manufacturers, which may increase the time before FDA inspects a facility again or shorten the time of the next inspection;
	if appropriate, make decisions related to applications submitted to the agency without conducting an inspection; and
	identify unreported adverse events or incomplete corrective actions, which resulted in the agency pivoting its oversight approach to conduct an inspection and take a regulatory action.The agency released a draft guidance – Conducting Remote Regulatory Assessments Questions and Answers – on the expanded use of RRAs and how the FDA generally intends this tool, once finalized, to be incorporated consistently across all FDA-regulated products beyond the current COVID-19 public health emergency.

The agency uses robust oversight tools to protect public health.



Related RRA Information
	Conducting Remote Regulatory Assessments Questions and Answers
	FDA Efforts to Ensure Product Safety

                                                                                  Content current as of:
      03/30/2023Inspection References

          
                        FDA's Remote Oversight Tools
          Inspection Citation
          Inspection Observations
          ORA Outbreak Response Field Guides


                        Inspection Guides
          Investigations Operations Manual
          Field Management Directives
          Foreign Inspections
          Nonclinical Laboratories Inspected under Good Laboratory Practices
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop